MedPath

Favorable and unfavorable effects of risk-reducing salpingo-oophorectomy (RRSO) in women at high genetic risk of ovarian cancer

Recruiting
Conditions
Botgezondheid
ovariectomy
RRSO
10074469
10003216
Registration Number
NL-OMON50443
Lead Sponsor
Antoni van Leeuwenhoek Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
750
Inclusion Criteria

Female patients
High genetic risk of ovarian cancer
Risk reducing salpingo-oophorectomy before the age of 46, or (for control
group):
High genetic risk for ovarian cancer
Natural menopause after age of 50 years
No RRSO before 55 years of age
No treatment induced menopause before 50 years of age

Exclusion Criteria

For both groups:
History of gynecological cancer at time of RRSO
History of cancer at time of testing for BRCA-1 / BRCA-2
Ovariectomy for other reasons in patient history
Cystectomy in patients history
Metastatic disease
Other serious comorbidity, psychiatric disorders, which would interfere with a
clinic visit
Not enough understanding of the Dutch language
Non-bioresorbable cardiac stent
Younger age than 55 years
Premature Ovarian Insufficiency

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath